Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1994 Apr;93(4):1709–1715. doi: 10.1172/JCI117154

Elevated expression of type VII collagen in the skin of patients with systemic sclerosis. Regulation by transforming growth factor-beta.

L Rudnicka 1, J Varga 1, A M Christiano 1, R V Iozzo 1, S A Jimenez 1, J Uitto 1
PMCID: PMC294224  PMID: 7512991

Abstract

A hallmark of systemic sclerosis (SSc) is the development of tissue fibrosis. Excessive production of several connective tissue components normally present in the dermis, including type I, III, V, and VI collagens as well as fibronectin and proteoglycans, is a consistent finding in the skin of SSc patients. Type VII collagen is a major constituent of anchoring fibrils, present in the skin at the dermal-epidermal basement membrane zone. TGF-beta has been shown to upregulate the expression of the type VII collagen gene. In this study, we assessed the expression of type VII collagen and TGF-beta in the skin of patients with SSc. Indirect immunofluorescence showed an abundance of type VII collagen in the patients' skin, including the dermis. Ultrastructural analysis of SSc skin revealed an abundance of fibrillar material, possibly representing type VII collagen. The increased expression of type VII collagen epitopes was accompanied by the elevated expression of immunodetectable TGF-beta 1 and TGF-beta 2. Dermal fibroblasts cultured from the affected individuals showed a statistically significant (P < 0.02) increase in the expression of type VII collagen at the mRNA level, as detected by reverse transcription-PCR with a mutated cDNA as an internal standard, and increased deposition of the protein as assessed by indirect immunofluorescence. Thus, type VII collagen is abundantly present in SSc patients' dermis, a location not characteristic of its normal distribution, and its aberrant expression may relate to the presence of TGF-beta in the same topographic distribution. The presence of type VII collagen in the dermis may contribute to the tightly bound and indurated appearance of the affected skin in SSc patients.

Full text

PDF
1709

Images in this article

1711Image
on p.1711
1712Image
on p.1712
1712Image
on p.1712
1712Image
on p.1712
1713Image
on p.1713
1713Image
on p.1713
1713Image
on p.1713
1713Image
on p.1713
1713Image
on p.1713

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Border W. A., Ruoslahti E. Transforming growth factor-beta in disease: the dark side of tissue repair. J Clin Invest. 1992 Jul;90(1):1–7. doi: 10.1172/JCI115821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Burgeson R. E., Lunstrum G. P., Rokosova B., Rimberg C. S., Rosenbaum L. M., Keene D. R. The structure and function of type VII collagen. Ann N Y Acad Sci. 1990;580:32–43. doi: 10.1111/j.1749-6632.1990.tb17915.x. [DOI] [PubMed] [Google Scholar]
  3. Christiano A. M., Greenspan D. S., Hoffman G. G., Zhang X., Tamai Y., Lin A. N., Dietz H. C., Hovnanian A., Uitto J. A missense mutation in type VII collagen in two affected siblings with recessive dystrophic epidermolysis bullosa. Nat Genet. 1993 May;4(1):62–66. doi: 10.1038/ng0593-62. [DOI] [PubMed] [Google Scholar]
  4. Christiano A. M., Rosenbaum L. M., Chung-Honet L. C., Parente M. G., Woodley D. T., Pan T. C., Zhang R. Z., Chu M. L., Burgeson R. E., Uitto J. The large non-collagenous domain (NC-1) of type VII collagen is amino-terminal and chimeric. Homology to cartilage matrix protein, the type III domains of fibronectin and the A domains of von Willebrand factor. Hum Mol Genet. 1992 Oct;1(7):475–481. doi: 10.1093/hmg/1.7.475. [DOI] [PubMed] [Google Scholar]
  5. Falanga V., Tiegs S. L., Alstadt S. P., Roberts A. B., Sporn M. B. Transforming growth factor-beta: selective increase in glycosaminoglycan synthesis by cultures of fibroblasts from patients with progressive systemic sclerosis. J Invest Dermatol. 1987 Jul;89(1):100–104. doi: 10.1111/1523-1747.ep12580445. [DOI] [PubMed] [Google Scholar]
  6. Fleischmajer R., Perlish J. S., Krieg T., Timpl R. Variability in collagen and fibronectin synthesis by scleroderma fibroblasts in primary culture. J Invest Dermatol. 1981 May;76(5):400–403. doi: 10.1111/1523-1747.ep12520933. [DOI] [PubMed] [Google Scholar]
  7. Gay R. E., Buckingham R. B., Prince R. K., Gay S., Rodnan G. P., Miller E. J. Collagen types synthesized in dermal fibroblast cultures from patients with early progressive systemic sclerosis. Arthritis Rheum. 1980 Feb;23(2):190–196. doi: 10.1002/art.1780230209. [DOI] [PubMed] [Google Scholar]
  8. Graves P. N., Weiss I. K., Perlish J. S., Fleischmajer R. Increased procollagen mRNA levels in scleroderma skin fibroblasts. J Invest Dermatol. 1983 Feb;80(2):130–132. doi: 10.1111/1523-1747.ep12532908. [DOI] [PubMed] [Google Scholar]
  9. Greenspan D. S. The carboxyl-terminal half of type VII collagen, including the non-collagenous NC-2 domain and intron/exon organization of the corresponding region of the COL7A1 gene. Hum Mol Genet. 1993 Mar;2(3):273–278. doi: 10.1093/hmg/2.3.273. [DOI] [PubMed] [Google Scholar]
  10. Gruschwitz M., Müller P. U., Sepp N., Hofer E., Fontana A., Wick G. Transcription and expression of transforming growth factor type beta in the skin of progressive systemic sclerosis: a mediator of fibrosis? J Invest Dermatol. 1990 Feb;94(2):197–203. doi: 10.1111/1523-1747.ep12874503. [DOI] [PubMed] [Google Scholar]
  11. Hovnanian A., Duquesnoy P., Blanchet-Bardon C., Knowlton R. G., Amselem S., Lathrop M., Dubertret L., Uitto J., Goossens M. Genetic linkage of recessive dystrophic epidermolysis bullosa to the type VII collagen gene. J Clin Invest. 1992 Sep;90(3):1032–1036. doi: 10.1172/JCI115916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ignotz R. A., Massagué J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem. 1986 Mar 25;261(9):4337–4345. [PubMed] [Google Scholar]
  13. Ishikawa H., Horiuchi R. Initial change of glycosaminoglycans in systemic scleroderma. Dermatologica. 1975;150(6):334–345. doi: 10.1159/000251454. [DOI] [PubMed] [Google Scholar]
  14. Jimenez S. A., Feldman G., Bashey R. I., Bienkowski R., Rosenbloom J. Co-ordinate increase in the expression of type I and type III collagen genes in progressive systemic sclerosis fibroblasts. Biochem J. 1986 Aug 1;237(3):837–843. doi: 10.1042/bj2370837. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kawanami O., Ferrans V. J., Roberts W. C., Crystal R. G., Fulmer J. D. Anchoring fibrils. A new connective tissue structure in fibrotic lung disease. Am J Pathol. 1978 Aug;92(2):389–410. [PMC free article] [PubMed] [Google Scholar]
  16. Kikuchi K., Hartl C. W., Smith E. A., LeRoy E. C., Trojanowska M. Direct demonstration of transcriptional activation of collagen gene expression in systemic sclerosis fibroblasts: insensitivity to TGF beta 1 stimulation. Biochem Biophys Res Commun. 1992 Aug 31;187(1):45–50. doi: 10.1016/s0006-291x(05)81456-1. [DOI] [PubMed] [Google Scholar]
  17. Kulozik M., Hogg A., Lankat-Buttgereit B., Krieg T. Co-localization of transforming growth factor beta 2 with alpha 1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis. J Clin Invest. 1990 Sep;86(3):917–922. doi: 10.1172/JCI114793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kähäri V. M., Chen Y. Q., Su M. W., Ramirez F., Uitto J. Tumor necrosis factor-alpha and interferon-gamma suppress the activation of human type I collagen gene expression by transforming growth factor-beta 1. Evidence for two distinct mechanisms of inhibition at the transcriptional and posttranscriptional levels. J Clin Invest. 1990 Nov;86(5):1489–1495. doi: 10.1172/JCI114866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kähäri V. M., Vuorio T., Näntö-Salonen K., Vuorio E. Increased type I collagen mRNA levels in cultured scleroderma fibroblasts. Biochim Biophys Acta. 1984 Feb 24;781(1-2):183–186. doi: 10.1016/0167-4781(84)90136-2. [DOI] [PubMed] [Google Scholar]
  20. König A., Bruckner-Tuderman L. Transforming growth factor-beta stimulates collagen VII expression by cutaneous cells in vitro. J Cell Biol. 1992 May;117(3):679–685. doi: 10.1083/jcb.117.3.679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lally E. V., Jimenez S. A., Kaplan S. R. Progressive systemic sclerosis: mode of presentation, rapidly progressive disease course, and mortality based on an analysis of 91 patients. Semin Arthritis Rheum. 1988 Aug;18(1):1–13. doi: 10.1016/0049-0172(88)90030-3. [DOI] [PubMed] [Google Scholar]
  22. Lapiere J. C., Woodley D. T., Parente M. G., Iwasaki T., Wynn K. C., Christiano A. M., Uitto J. Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J Clin Invest. 1993 Oct;92(4):1831–1839. doi: 10.1172/JCI116774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. LeRoy E. C. Increased collagen synthesis by scleroderma skin fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast. J Clin Invest. 1974 Oct;54(4):880–889. doi: 10.1172/JCI107827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. LeRoy E. C., Mercurio S., Sherer G. K. Replication and phenotypic expression of control and scleroderma human fibroblasts: responses to growth factors. Proc Natl Acad Sci U S A. 1982 Feb;79(4):1286–1290. doi: 10.1073/pnas.79.4.1286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Leroy E. C., Smith E. A., Kahaleh M. B., Trojanowska M., Silver R. M. A strategy for determining the pathogenesis of systemic sclerosis. Is transforming growth factor beta the answer? Arthritis Rheum. 1989 Jul;32(7):817–825. [PubMed] [Google Scholar]
  26. Ohta A., Uitto J. Procollagen gene expression by scleroderma fibroblasts in culture. Inhibition of collagen production and reduction of pro alpha 1(I) and pro alpha 1(III) collagen messenger RNA steady-state levels by retinoids. Arthritis Rheum. 1987 Apr;30(4):404–411. doi: 10.1002/art.1780300407. [DOI] [PubMed] [Google Scholar]
  27. Paller A. S., Queen L. L., Woodley D. T., Gammon W. R., O'Keefe E. J., Briggaman R. A. A mouse monoclonal antibody against a newly discovered basement membrane component, the epidermolysis bullosa acquisita antigen. J Invest Dermatol. 1985 Mar;84(3):215–217. doi: 10.1111/1523-1747.ep12265158. [DOI] [PubMed] [Google Scholar]
  28. Peltonen J., Kähäri L., Uitto J., Jimenez S. A. Increased expression of type VI collagen genes in systemic sclerosis. Arthritis Rheum. 1990 Dec;33(12):1829–1835. doi: 10.1002/art.1780331211. [DOI] [PubMed] [Google Scholar]
  29. Perlish J. S., Lemlich G., Fleischmajer R. Identification of collagen fibrils in scleroderma skin. J Invest Dermatol. 1988 Jan;90(1):48–54. doi: 10.1111/1523-1747.ep12462561. [DOI] [PubMed] [Google Scholar]
  30. Roberts A. B., Kim S. J., Noma T., Glick A. B., Lafyatis R., Lechleider R., Jakowlew S. B., Geiser A., O'Reilly M. A., Danielpour D. Multiple forms of TGF-beta: distinct promoters and differential expression. Ciba Found Symp. 1991;157:7–28. doi: 10.1002/9780470514061.ch2. [DOI] [PubMed] [Google Scholar]
  31. Roberts A. B., Sporn M. B., Assoian R. K., Smith J. M., Roche N. S., Wakefield L. M., Heine U. I., Liotta L. A., Falanga V., Kehrl J. H. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A. 1986 Jun;83(12):4167–4171. doi: 10.1073/pnas.83.12.4167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Rodnan G. P., Lipinski E., Luksick J. Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma. Arthritis Rheum. 1979 Feb;22(2):130–140. doi: 10.1002/art.1780220205. [DOI] [PubMed] [Google Scholar]
  33. Ryynänen J., Sollberg S., Olsen D. R., Uitto J. Transforming growth factor-beta up-regulates type VII collagen gene expression in normal and transformed epidermal keratinocytes in culture. Biochem Biophys Res Commun. 1991 Oct 31;180(2):673–680. doi: 10.1016/s0006-291x(05)81118-0. [DOI] [PubMed] [Google Scholar]
  34. Ryynänen J., Sollberg S., Parente M. G., Chung L. C., Christiano A. M., Uitto J. Type VII collagen gene expression by cultured human cells and in fetal skin. Abundant mRNA and protein levels in epidermal keratinocytes. J Clin Invest. 1992 Jan;89(1):163–168. doi: 10.1172/JCI115557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Ryynänen M., Ryynänen J., Sollberg S., Iozzo R. V., Knowlton R. G., Uitto J. Genetic linkage of type VII collagen (COL7A1) to dominant dystrophic epidermolysis bullosa in families with abnormal anchoring fibrils. J Clin Invest. 1992 Mar;89(3):974–980. doi: 10.1172/JCI115680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Sakai L. Y., Keene D. R., Morris N. P., Burgeson R. E. Type VII collagen is a major structural component of anchoring fibrils. J Cell Biol. 1986 Oct;103(4):1577–1586. doi: 10.1083/jcb.103.4.1577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Scharffetter K., Lankat-Buttgereit B., Krieg T. Localization of collagen mRNA in normal and scleroderma skin by in-situ hybridization. Eur J Clin Invest. 1988 Feb;18(1):9–17. doi: 10.1111/j.1365-2362.1988.tb01158.x. [DOI] [PubMed] [Google Scholar]
  38. Uitto J., Bauer E. A., Eisen A. Z. Scleroderma: increased biosynthesis of triple-helical type I and type III procollagens associated with unaltered expression of collagenase by skin fibroblasts in culture. J Clin Invest. 1979 Oct;64(4):921–930. doi: 10.1172/JCI109558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Uitto J., Christiano A. M. Molecular genetics of the cutaneous basement membrane zone. Perspectives on epidermolysis bullosa and other blistering skin diseases. J Clin Invest. 1992 Sep;90(3):687–692. doi: 10.1172/JCI115938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Uitto J., Chung-Honet L. C., Christiano A. M. Molecular biology and pathology of type VII collagen. Exp Dermatol. 1992 Jul;1(1):2–11. doi: 10.1111/j.1600-0625.1992.tb00065.x. [DOI] [PubMed] [Google Scholar]
  41. Varga J., Jimenez S. A. Stimulation of normal human fibroblast collagen production and processing by transforming growth factor-beta. Biochem Biophys Res Commun. 1986 Jul 31;138(2):974–980. doi: 10.1016/s0006-291x(86)80591-5. [DOI] [PubMed] [Google Scholar]
  42. Varga J., Olsen A., Herhal J., Constantine G., Rosenbloom J., Jimenez S. A. Interferon-gamma reverses the stimulation of collagen but not fibronectin gene expression by transforming growth factor-beta in normal human fibroblasts. Eur J Clin Invest. 1990 Oct;20(5):487–493. doi: 10.1111/j.1365-2362.1990.tb01890.x. [DOI] [PubMed] [Google Scholar]
  43. Woodley D. T., Briggaman R. A., O'Keefe E. J., Inman A. O., Queen L. L., Gammon W. R. Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita. N Engl J Med. 1984 Apr 19;310(16):1007–1013. doi: 10.1056/NEJM198404193101602. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES